Sabby Management’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,682
| Closed | -$40K | – | 146 |
|
|
2021
Q4 | $40K | Buy |
2,682
+1,213
| +83% | +$18.1K | 0.01% | 99 |
|
|
2021
Q3 | $44K | Sell |
1,469
-842
| -36% | -$25.2K | 0.01% | 89 |
|
|
2021
Q2 | $78K | Sell |
2,311
-4,249
| -65% | -$143K | 0.01% | 81 |
|
|
2021
Q1 | $272K | Sell |
6,560
-3,840
| -37% | -$159K | 0.05% | 64 |
|
|
2020
Q4 | $629K | Buy |
10,400
+9,328
| +870% | +$564K | 0.12% | 26 |
|
|
2020
Q3 | $143K | Buy |
+1,072
| New | +$143K | 0.02% | 59 |
|
|
2020
Q2 | – | Sell |
-1,470
| Closed | -$211K | – | 99 |
|
|
2020
Q1 | $211K | Sell |
1,470
-2,673
| -65% | -$384K | 0.09% | 31 |
|
|
2019
Q4 | $1.37M | Buy |
+4,143
| New | +$1.37M | 0.38% | 4 |
|
|
2018
Q1 | – | Sell |
-40
| Closed | -$60K | – | 134 |
|
|
2017
Q4 | $60K | Buy |
+40
| New | +$60K | 0.01% | 66 |
|